Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christel Lucas
Observed names:
C Lucas,
C. Lucas
Institutions:
Université de Bretagne Occidentale,
Centre Hospitalier Régional Universitaire de Brest,
Université de Bretagne Occidentale
Observed institutions:
Université de Bretagne Occidentale,
Charles University,
Centre Hospitalier Régional Universitaire de Brest,
Pierre Fabre (France),
Centre Antoine Lacassagne,
Takeda (France),
Université de Bretagne Occidentale,
Institut de Recherche Pierre Fabre (France),
Takeda (Japan)
show all 9
OpenAlex ID:
A5113719905
Treatment of Central Precocious Puberty by Subcutaneous Injections of Leuprorelin 3-Month Depot (11.25 mg)
2002
·
Jean-Claude Carel
, Najiba Lahlou
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
109
Vinflunine–gemcitabine versus vinflunine–carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)
2015
·
M. De Santis
, P.J. Wiechno
, et al.
·
Annals of Oncology
·
56
Leuprorelin depot 3.75 mg versus lynestrenol in the preoperative treatment of symptomatic uterine myomas: a multicentre randomised trial
2000
·
Eric Verspyck
, Loı̈c Marpeau
, et al.
·
European Journal of Obstetrics & Gynecology and Reproductive Biology
·
31
Prevention of Menstruation with Leuprorelin (GnRH Agonist) in Women Undergoing Myelosuppressive Chemotherapy or Radiochemotherapy for Hematological Malignancies: a Pilot Study
2001
·
C. Lhommé
, PH. Brault
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
26
Intermittent Androgen Castration: A Biological Reality during Intermittent Treatment in Metastatic Prostate Cancer?
2005
·
N. Mottet
, C. Lucas
, et al.
·
Urologia Internationalis
·
16
Fractionated Scheme of Oral Vinorelbine as Single-Agent Therapy or in Combination With Cisplatin Concomitantly With Thoracic Radiotherapy in Stage III Non–Small-Cell Lung Cancer: Dose-Escalation Phase I Trial
2014
·
Maciej Krzakowski
, Christel Lucas
, et al.
·
Clinical Lung Cancer
·
13
Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy
2016
·
N. Houédé
, G. Locker
, et al.
·
BMC Cancer
·
7
PDF
Updated Survival Results of the Phase Iii Trial Comparing Vinflunine (v) to Best Supportive Care (bsc) in Advanced Transitional Cell Carcinoma of the Urothelium (tccu) After Failure of a Prior Platinum-containing Regimen
2010
·
S. Culine
, C. Lucas
, et al.
·
European Urology Supplements
·
7
[Management of locally advanced prostatic adenocarcinoma in France. OCTAVE observational survey].
2006
·
Arnauld Villers
, Jérémie Haffner
, et al.
·
PubMed
·
7
Mature Survival (Os) Data of a Randomised International Phase Ii Trial (Jasint1): Vinflunine (Vfl)-Gemcitabine (Gem) Vs. Vfl-Cbdca in Cddp-Unfit Patients (Pts) with Advanced Urothelial Carcinoma (Uc)
2014
·
M. De Santis
, P.J. Wiechno
, et al.
·
Annals of Oncology
·
6
[Effectiveness and tolerance of three month sustained release leuprorelin in the treatment of metastatic prostatic cancer (comparative, randomized, multicentric study].
1997
·
M Zerbib
, C Lucas
, et al.
·
PubMed
·
4
Direct comparison between Grade Group assessed on systematic and MRI/ultrasound fusion targeted biopsies correlated to the radical prostatectomy specimens in patients with prostate cancer
2023
·
C. Payrard-Starck
, A. Fourcade
, et al.
·
The French Journal of Urology
·
3
PDF
Feasibility and activity of two vinflunine (VFL)-based combinations as first-line chemotherapy (CT) in CDDP-unfit patients (pts) with advanced urothelial carcinoma (UC): VFL-gemcitabine (GEM) or VFL-CBDCA in a randomized international phase II trial (JASINT).
2014
·
Maria De Santis
, Pawel J. Wiechno
, et al.
·
Journal of Clinical Oncology
·
3
Characteristics and treatments patterns of patients with an advanced or metastatic urothelial carcinoma (UC) after failure of a platinum-based chemotherapy (CT): Results of the European observational study EPICURE
2015
·
N. Houede
, G.J. Locker
, et al.
·
European Journal of Cancer
Oral vinorelbine (NVBo) at 3-weekly flat-dose intakes (FDI) as single agent or with cisplatin (CDDP) concomitantly with thoracic radiotherapy (RT) in stage III NSCLC: Escalation-dose phase I trial results.
2011
·
D. M. Kowalski
, M. J. Krzakowski
, et al.
·
Journal of Clinical Oncology
Oral vinorelbine (NVBo) and anastrozole (A) as neoadjuvant treatment of locally advanced (LA) breast cancer (BC) in hormone receptor positive (HR+) postmenopausal patients: Results of an international phase II trial
2009
·
M. Riggi
, E. M. Moreno-Lopez
, et al.
·
Journal of Clinical Oncology
Phase I trial and pharmacokinetic (PK) study of S16020 according to a weekly and every 2 week (W) schedule in cancer patients (PT)
1999
·
E. Brian
, M. Di Palma
, et al.
·
European Journal of Cancer
Clinical and pharmacokinetic phase II study of fotemustine(F), cisplatin (C) and high-dose tamoxifen (T) in metastatic malignant melanoma (MMM)
1997
·
K A Semb
, S Aamdal
, et al.
·
Melanoma Research
Tolérance et réponses clinique et biologique au cours des 6 pr emiers mois de traitement par la leuproréline ou la triptoréline, agonistes de la LHRH à libération pr olongée sur 1 mois chez des patients présentant un cancer de la pr ostate métastasé
1997
·
Claude Clément Abbou
, C. Lucas
, et al.
Show more works
View as search
Works count:
19
Citation count:
288
H-index:
7
I10-index:
6
Year
Topic
Type